| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Poseida Therapeutics Inc (NASDAQ: PSTX)
PSTX Technical Analysis
5
| As on 9th Jun 2023 PSTX STOCK Price closed @ 2.20 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.78 & Strong Sell for SHORT-TERM with Stoploss of 4.96 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PSTXSTOCK Price
| Open | 2.32 | Change | Price | % |
| High | 2.35 | 1 Day | -0.11 | -4.76 |
| Low | 2.18 | 1 Week | -0.07 | -3.08 |
| Close | 2.20 | 1 Month | -0.21 | -8.71 |
| Volume | 759025 | 1 Year | -4.70 | -68.12 |
| 52 Week High 8.73 | 52 Week Low 1.87 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| PSTX Daily Charts |
PSTX Intraday Charts |
Whats New @ Bazaartrend |
PSTX Free Analysis |
|
|
PSTX Important Levels Intraday
| RESISTANCE | 2.53 |
| RESISTANCE | 2.42 |
| RESISTANCE | 2.36 |
| RESISTANCE | 2.29 |
| SUPPORT | 2.11 |
| SUPPORT | 2.04 |
| SUPPORT | 1.98 |
| SUPPORT | 1.87 |
PSTX Forecast April 2024
| 4th UP Forecast | 8.39 |
| 3rd UP Forecast | 6.4 |
| 2nd UP Forecast | 5.18 |
| 1st UP Forecast | 3.95 |
| 1st DOWN Forecast | 0.45 |
| 2nd DOWN Forecast | -0.78 |
| 3rd DOWN Forecast | -2 |
| 4th DOWN Forecast | -3.99 |
PSTX Weekly Forecast
| 4th UP Forecast | 3.61 |
| 3rd UP Forecast | 3.16 |
| 2nd UP Forecast | 2.88 |
| 1st UP Forecast | 2.60 |
| 1st DOWN Forecast | 1.80 |
| 2nd DOWN Forecast | 1.52 |
| 3rd DOWN Forecast | 1.24 |
| 4th DOWN Forecast | 0.79 |
PSTX Forecast2024
| 4th UP Forecast | 15.69 |
| 3rd UP Forecast | 11.36 |
| 2nd UP Forecast | 8.69 |
| 1st UP Forecast | 6.02 |
| 1st DOWN Forecast | -1.62 |
| 2nd DOWN Forecast | -4.29 |
| 3rd DOWN Forecast | -6.96 |
| 4th DOWN Forecast | -11.29 |
Poseida Therapeutics Inc ( NASDAQ USA Symbol : PSTX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PSTX Business Profile
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company is developing P-BCMA-101, an autologous chimeric antigen receptor T cell (CAR-T) targeting B cell maturation antigen that is in Phase II clinical trial; P-PSMA-101, an autologous CAR-T product candidate for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC) is in Phase I clinical trials; P-BCMA-ALLO1, an allogeneic CAR-T product candidate to treat relapsed/refractory multiple myeloma patients; P-MUC1C-ALLO1, an allogeneic CAR-T product candidate for multiple solid tumor indications; and P-PSMA-ALLO1, an allogeneic CAR-T product candidate for treating mCRPC. It is also developing P-OTC-101, a liver-directed gene therapy for the treatment of ornithine transcarbamylase; and P-MMUT-101, a liver-directed gene therapy for the treatment of methylmalonic acidemia. In addition, the company is developing a portfolio of allogeneic dual CAR product candidates. It has a research collaboration and license agreement with Takeda Pharmaceutical Company Limited. The company was incorporated in 2014 and is headquartered in San Diego, California. Address: 9390 Towne Centre Drive, San Diego, CA, United States, 92121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service